About this trial
This prospective, multicenter registry will consecutively enroll patients of all ages undergoing percutaneous coronary intervention (PCI) at four university hospitals in Gangwon Province, Republic of Korea.
The study will describe contemporary clinical, procedural, and medication treatment patterns and assess 1-year clinical outcomes in routine practice.
The primary outcome is patient-oriented composite outcome (POCO), defined as all-cause death, any myocardial infarction, or any repeat revascularization.
No study-specific intervention will be assigned.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients of any age undergoing percutaneous coronary intervention (PCI) at a participating hospital during the study period.
Written informed consent is obtained from the patient or a legally authorized representative before collection of study data, unless the requirement for informed consent is waived by the Institutional Review Board.
Disqualifiers
Refusal or withdrawal of informed consent, when informed consent is required.
No PCI performed during the index hospital encounter.
Trial population
The study population will consist of consecutive, all-comer patients of any age undergoing percutaneous coronary intervention (PCI) at four participating university hospitals in Gangwon Province, Republic of Korea. Patients undergoing PCI for any clinical presentation, including chronic coronary syndrome and acute coronary syndrome, will be eligible. There will be no restrictions based on sex, clinical presentation, comorbidity, lesion complexity, or procedural characteristics. Patients undergoing staged PCI during the same hospitalization will be included. Information on the initial and subsequent procedures will be recorded separately using dedicated electronic case report forms.
Trial design
Cohort
Prospective
Treatments tested in this trial
Percutaneous Coronary Intervention (PCI)
Procedure/SurgeryPCI performed as part of routine clinical care; no study-specific procedure is assigned.
Treatment groups
Trial outcomes
Primary outcomes
Patient-oriented composite outcome (POCO)
A composite of all-cause death, any myocardial infarction, or any repeat revascularization.
Secondary outcomes
Device-oriented composite outcome (DOCO)
A composite of cardiac death, target-vessel myocardial infarction, and clinically indicated target lesion revascularization.
All-cause death
Death from any cause
Cardiovascular death
Death resulting from a cardiovascular cause.
Any myocardial infarction
Any myocardial infarction occurring after the index PCI procedure.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yonsei University
Lead sponsor
Gangwon Cardiovascular Health Research Institute
Collaborator